Is the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?
Central European Journal of Urology · 2026 · 79 (2) · 103-110
DOI: 10.5173/ceju.2025.0244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central European Journal of Urology, 2026. Verfasst von Levent Ozcan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
Zitieren
APA
Ozcan, L., Boylu, A., Polat, E. C., Culha, M. G., Erkoc, M., Bozkurt, M., Danis, E., & Otunctemur, A. (2026). Is the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?. Central European Journal of Urology, 79(2), 103-110. https://doi.org/10.5173/ceju.2025.0244
Vancouver
Ozcan L, Boylu A, Polat EC, Culha MG, Erkoc M, Bozkurt M, et al. Is the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?. Central European Journal of Urology. 2026;79(2):103-110. doi:10.5173/ceju.2025.0244
BibTeX
@article{Ozcan2026,
author = {Ozcan, Levent and Boylu, Ahmet and Polat, Emre Can and Culha, Mehmet Gokhan and Erkoc, Mustafa and Bozkurt, Muammer and Danis, Eyyup and Otunctemur, Alper},
title = {Is the albumin/globulin ratio a predictor of response to neoadjuvant chemotherapy before cystectomy for muscle-invasive bladder cancer?},
journal = {Central European Journal of Urology},
year = {2026},
volume = {79},
number = {2},
pages = {103--110},
doi = {10.5173/ceju.2025.0244}
}
EUVIMED